| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2506ab8b51dd5918eef67cee395d899 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175 |
| filingDate |
2018-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cf5590e4c78054ee189d5193b33d5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f04acce6297736c256e801722e53bf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2320f40c0a073e4f551fbe10ec0d1e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4ce728262dd0cccf2b0abecfbe4082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0def1eb7ee9a050cbf12ef1e5b4136df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9da5123af115832c94dee74c6460b09b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0799b9989061e2ffc84617612ab7c187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a8d77746924a1079bebe35a45085fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f130f7e1503c62313b618fb3f0195f42 |
| publicationDate |
2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019059470-A1 |
| titleOfInvention |
COMPOSITION FOR THE PREVENTION OR TREATMENT OF COLORECTAL CANCER CONTAINING RAMALIN AS ACTIVE INGREDIENT |
| abstract |
The present invention relates to a composition for the prevention or treatment of colorectal cancer containing ramaline as an active ingredient. According to the present invention, the composition containing ramaline as active ingredient has anti-cancer effects by apoptosis, disruption of the cell cycle and inhibition of cancer cell migration and invasion, which allows it to be used effectively in as a composition for the prevention or treatment of colorectal cancer. |
| priorityDate |
2017-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |